Demand, speculators threaten Chinese medicine plants

China may have begun overfishing the raw material base for its traditional medicines. Industry groups want to establish a reserve to ensure a future for the business as some natural resources, including Ginseng, are exploited. More than 150 traditional Chinese medicine plants are now considered endangered. Story

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.